Catholicon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-07-2024
- Paid Up Capital ₹ 0.10 M
as on 31-07-2024
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 31-07-2024
- Revenue -2.43%
(FY 2023)
- Profit 0.37%
(FY 2023)
- Ebitda 65.93%
(FY 2023)
- Net Worth 17.26%
(FY 2023)
- Total Assets 18.76%
(FY 2023)
About Catholicon Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Gaurav Banga and Raakhee Banga serve as directors at the Company.
- CIN/LLPIN
U24232CH2007PTC030660
- Company No.
030660
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Catholicon Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Banga  | Director | 04-Jan-2007 | Current |
| Raakhee Banga | Director | 31-Jul-2010 | Current |
Financial Performance of Catholicon Pharmaceuticals.
Catholicon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.43% decrease. The company also saw a slight improvement in profitability, with a 0.37% increase in profit. The company's net worth Soared by an impressive increase of 17.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Catholicon Pharmaceuticals?
In 2023, Catholicon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 13 Mar 2023 | ₹3.50 M | Open |
How Many Employees Work at Catholicon Pharmaceuticals?
Unlock and access historical data on people associated with Catholicon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Catholicon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catholicon Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
